Literature DB >> 3144181

Acidosis-induced glucose intolerance is not prevented by adrenergic blockade.

H J Adrogué1, Z Chap, Y Okuda, L Michael, C Hartley, M Entman, J B Field.   

Abstract

The determinants of the altered glucoregulation in acidosis were investigated in anesthetized dogs. Because CO2 rapidly equilibrates and its effects are mediated by pH changes, CO2 inhalation was examined. Plasma acid-base composition, glucose, insulin, glucagon, and blood flows were evaluated before and after an intravenous glucose load (1.2 +/- 0.1 g/kg body wt) in normal and acidotic dogs with flow probes and catheters chronically implanted in the portal circulation. A simultaneous infusion of phentolamine (5 micrograms.kg-1.min-1), propranolol (3.5 micrograms.kg-1.min-1), both, or none was used. All acidemic dogs had lower hepatic extraction of insulin and greater hyperglycemia after the glucose challenge; thus the adrenergic system is not critical for these responses. Because arterial insulin levels were either normal (propranolol) or increased (all others) in acidosis, insulin resistance was likely. Insulin infusion (2 and 4 mU.kg-1.min-1) with euglycemic clamp and [3-3H]glucose documented that acidemia decreases peripheral glucose utilization and the insulin suppression of hepatic glucose production. Acidemia also enhances plasma glucagon levels, yet this effect plays a limited role in the observed hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144181     DOI: 10.1152/ajpendo.1988.255.6.E812

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Adrenocorticotrophic hormone, cortisol and catecholamine concentrations during insulin hypoglycaemia in dogs anaesthetized with thiopentone.

Authors:  C F Toso; R R Rodríguez; A R Renauld; A G Márquez; L M Linares
Journal:  Can J Anaesth       Date:  1993-11       Impact factor: 5.063

2.  Blood sugar, serum insulin and serum non-esterified fatty acid levels during thiopentone anaesthesia in dogs.

Authors:  C F Toso; R R Rodríguez; A Renauld; R C Sverdlik; L M Linares
Journal:  Can J Anaesth       Date:  1993-01       Impact factor: 5.063

3.  Phase II study of tight glycaemic control in COPD patients with exacerbations admitted to the acute medical unit.

Authors:  John R H Archer; Shivani Misra; Marcus Simmgen; Paul W Jones; Emma H Baker
Journal:  BMJ Open       Date:  2011-07-23       Impact factor: 2.692

4.  Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Andrew W Hitchings; Dilys Lai; Paul W Jones; Emma H Baker
Journal:  Thorax       Date:  2016-02-25       Impact factor: 9.139

5.  Analysis of prevalence and prognosis of type 2 diabetes mellitus in patients with acute exacerbation of COPD.

Authors:  Li Lin; Jianxin Shi; Jian Kang; Qiuyue Wang
Journal:  BMC Pulm Med       Date:  2021-01-06       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.